Rigel Pharmaceuticals, Inc. Financial Ratios — RIGL Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-38.74	-34.86	-33.21	-47.82	-36	-65.96	-79.08	-54.59	-46.67	-23.06	-12.9	-38.84	-19.95	12.44	108.34
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.87	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.61	- -
Gross Margin (%)	100	100	100	100	100	100	100	99.36	98.47	99.18	99.27	98.55	93.92	89.6	93.33
EBITDA Margin (%)	-1,777.12	-4,308.62	-1,191.58	-1,077.45	-174.09	-309.23	-1,765.19	-161.96	-115.38	-26.02	-5.24	-44.27	-16.47	14.74	43.46
Operating Margin (%)	-1,818.27	-4,416.76	-1,227.83	-1,106.05	-179.07	-313.84	-1,775.56	-163.3	-116.53	-26.67	-6.01	-45.1	-17.53	13.49	42.63
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71.61	88.06
Pretax Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-11.6	-48.71	-21.47	10.24	41.4
Profit Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-12	-48.71	-21.47	9.75	124.72
Net Income to Common Margin (%)	-1,809.96	-4,392.89	-1,245.13	-1,101.92	-178.11	-339.58	-1,739.34	-158.35	-112.83	-27.38	-12	-48.71	-21.47	9.75	124.72
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.8	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	39	31	42	61	60	53
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	7	9	10	1	8	8	30
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	29	30	21	40	53	52	23
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.53	-1.38	-3.91	-0.78	-3.15	2.27	0.42
Net Debt/EBITDA	0.22	0.35	0.24	0.17	0.86	0.28	0.48	1.06	0.19	0.37	-0.13	-0.28	-1.39	0.11	0.09
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.53	-1.35	-3.41	-0.77	-2.96	2.48	0.42
Net Debt/EBIT	0.22	0.34	0.24	0.17	0.84	0.28	0.48	1.05	0.18	0.36	-0.11	-0.28	-1.31	0.12	0.09
EBITDA to Interest Expense	-3,376.52	- -	- -	- -	- -	- -	- -	- -	-204.2	-20.89	-1.61	-14.36	-2.8	3.34	17.47
EBITDA-CapEx/Interest Expense	-3,376.52	- -	- -	- -	- -	- -	- -	- -	-204.2	-21.82	-1.74	-14.48	-4.98	3.29	17.47
EBIT to Interest Expense	-3,454.72	- -	- -	- -	- -	- -	- -	- -	-206.24	-21.41	-1.85	-14.63	-2.98	3.06	17.14
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	5	4	7	8	7
Common Equity/Total Assets	-257.22	-245.18	-375.65	-609.92	-752.62	-1,357.62	-956	-869.22	-864.72	-1,183.03	-791.09	-1,029.41	-1,200.71	-847.71	-199.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	53.96	89.54	68.06	- -	- -	1,593.92	5.84
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.34	-2.41	-1.6	-3.01	-3.91	-3.94	-2.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	19.68	27.6	12.35	30.1	44.92	31.96	4.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.48	114.87	100.63	-305.18	-211.49	1,823.75	13.62
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.93	-3.09	-2.36	-3.1	-4.5	-4.51	-5.5
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	24.61	35.41	18.27	30.95	51.68	36.57	10.38
Net Debt to Equity	-7.89	-11.58	-10.01	-11.85	-47.55	-32.04	-38.04	-69.46	-23.62	-31.03	3.37	-110.08	-93.62	89.23	2.99
Net Debt/Capital (%)	2.74	4.22	2.4	1.59	4.2	1.64	3.25	5.94	1.01	0.81	-0.08	-1.1	-1.94	-0.21	-1.16
EBITDA	-84	-97	-85	-89	-50	-63	-79	-72	-68	-28	-8	-53	-19	26	128
EBITDA-CapEx	-84	-97	-85	-89	-50	-63	-79	-72	-68	-30	-8	-54	-34	26	128
Operating Income (Loss)	-86	-99	-88	-91	-52	-64	-80	-73	-69	-29	-9	-54	-20	24	125

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	21.48	24.44	20.59	10.21	3.74	3.31	6.31	4.63	1.68	1.4	1.97	0.89	1.07	1.22	1.56
Current Ratio	21.71	24.78	21.38	10.73	3.82	3.37	6.4	4.94	2.04	2.18	2.43	1.78	1.86	2.13	2.42
Quick Ratio	21.48	24.44	21.15	10.62	3.74	3.31	6.31	4.78	1.86	1.79	2.21	1.51	1.64	1.88	2.08
CFO/Avg Current Liab	-6.07	-7.18	-7.65	-5.74	-0.98	-2.69	-3.79	-2.55	-0.97	-1.05	0.11	-1.15	-0.1	0.54	0.93
Common Equity/Total Assets	-257.22	-245.18	-375.65	-609.92	-752.62	-1,357.62	-956	-869.22	-864.72	-1,183.03	-791.09	-1,029.41	-1,200.71	-847.71	-199.19
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	53.96	89.54	68.06	- -	- -	1,593.92	5.84
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.34	-2.41	-1.6	-3.01	-3.91	-3.94	-2.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	19.68	27.6	12.35	30.1	44.92	31.96	4.45
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.48	114.87	100.63	-305.18	-211.49	1,823.75	13.62
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.93	-3.09	-2.36	-3.1	-4.5	-4.51	-5.5
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	24.61	35.41	18.27	30.95	51.68	36.57	10.38
CFO/Total Liabilities	-331.03	-406.78	-483.39	-269.43	-58	-328.42	-420.02	-201.24	-44.28	-68.35	4.29	-49.87	-3.94	19.59	61.95
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	-41.35	9.37	-163.91	-0.38	87.42	- -
Altman's Z-Score	10.73	10.6	2.99	-4.77	-6.76	-14.79	1.37	-5.05	-10.46	-11.28	-7.73	-15.15	-17.02	-10.59	2.65

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	2.49	1.43	9.71	200.82	- -	21.83	8.36	8.33	9.49	4.31	3.3	4.97	6.3
Days Sales Outstanding	- -	- -	146.77	254.39	37.6	1.82	- -	16.72	43.67	43.83	38.45	84.68	110.66	73.46	57.91
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.64	0.81	0.6	0.26	0.22	0.97	3.24	2.24
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	568.48	452.83	610.1	1,390.91	1,641.77	375.78	112.79	162.85
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	0.26	0.26	0.3	1.62	0.32	0.24	3.65	4.77
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	1,394.94	1,408.56	1,216.51	225.89	1,129.22	1,539.88	100	76.49
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	-809.74	-912.06	-562.59	1,203.47	597.23	-1,053.44	86.24	144.27
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-551.77	-409.15	-566.28	-1,352.46	-1,557.09	-265.12	-39.32	-104.94
Inventories	- -	- -	- -	- -	- -	- -	- -	1	1	2	7	9	6	6	12
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	5	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	3	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	2	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	6	12

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	500	487	249	199	268	225	490	369	358	591	452	259	252	296	770
- Cash & Cash Equivalents	19	33	21	15	43	18	38	76	23	30	19	24	33	57	41
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	36	39	31	42	61	60	53
Enterprise Value	252	189	37	56	142	150	374	241	296	572	357	242	256	278	669
Total Capital	-661	-760	-849	-940	-992	-1,061	-1,139	-1,209	-1,240	-1,267	-1,293	-1,341	-1,347	-1,330	-970
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-2.93	-3.09	-2.36	-3.1	-4.5	-4.51	-5.5
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.12	0.07	0.09	0.17	0.24	0.22	0.08
EV/Sales	53.06	84.02	5.15	6.77	4.9	7.35	83.49	5.41	5	5.27	2.39	2.01	2.19	1.55	2.27
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.53	5.23
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.5	5.33
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.77	- -	226.71	7.13	6.84
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30.98	- -	15.87	7.07	6.84
Diluted Market Cap	500	487	249	199	268	225	490	369	358	591	452	259	252	297	807
Diluted Enterprise Value	481	454	228	184	224	207	452	293	372	599	463	276	280	301	820
EV per Share	39.8	25.22	4.22	6.37	16.02	15.88	29.64	14.99	17.71	33.92	20.96	14.03	14.71	15.83	37.18
TTM Sales	5	2	7	8	29	20	4	45	59	109	149	120	117	179	294
TTM EBITDA	-84	-97	-85	-89	-50	-63	-79	-72	-68	-28	-8	-53	-19	26	128
TTM Operating Income	-86	-99	-88	-91	-52	-64	-80	-73	-69	-29	-9	-54	-20	24	125
TTM Cash Flow to Firm	-69	-85	-86	-70	-23	-76	-78	-59	-41	-51	11	-70	1	39	98
TTM Free Cash Flow to Firm	-69	-85	-86	-70	-23	-76	-78	-59	-41	-50	12	-70	16	39	98

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-7.2	-5.72	-2.89	-2.85	-11.44	-2.96	-6.32	-6.28	-8.63	-11.6	69.45	-3.53	27.26	9.35	10.67
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.5	5.33
Enterprise Value	252	189	37	56	142	150	374	241	296	572	357	242	256	278	669
Low Price	64.2	53.7	23.1	15.6	20.2	18.82	19.4	19.6	15.6	12.3	23	6.4	7.12	7.48	15.5
EV/Sales	53.06	84.02	5.15	6.77	4.9	7.35	83.49	5.41	5	5.27	2.39	2.01	2.19	1.55	2.27
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.53	5.23
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.91	2.1
Price/Earnings Average	-5.68	-6.71	-4.36	-2.84	-5.41	-3.64	-4.67	-7.61	-5.42	-13.18	-34.91	-5.12	-8.95	13.81	1.32
Price/Earnings High	-7.52	-8.68	-7.46	-4.82	-8.94	-5.97	-7.25	-10.73	-6.73	-29.73	-52.34	-10.35	-14.15	29.98	2.56
Price/Earnings Low	-4.73	-4.07	-2.26	-1.5	-3.47	-2.57	-3.14	-4.46	-3.9	-6.98	-21.89	-1.88	-4.94	7.52	0.76
Price/Book Value	-0.76	-0.64	-0.29	-0.21	-0.27	-0.21	-0.43	-0.31	-0.28	-0.45	-0.34	-0.19	-0.18	-0.21	-0.75
Price/Book Value Average	-0.74	-0.87	-0.46	-0.27	-0.28	-0.24	-0.32	-0.44	-0.28	-0.3	-0.47	-0.22	-0.16	-0.17	-0.47
Price/Book Value High	-0.98	-1.13	-0.78	-0.47	-0.46	-0.39	-0.5	-0.63	-0.35	-0.68	-0.71	-0.44	-0.25	-0.38	-0.92
Price/Book Value Low	-0.61	-0.53	-0.24	-0.15	-0.18	-0.17	-0.22	-0.26	-0.2	-0.16	-0.3	-0.08	-0.09	-0.09	-0.27
Price/Tangible Book Value	2.12	1.69	1.19	1.55	2.93	4.08	4.87	3.36	6.66	17.36	14.87	-9.05	-5.93	-12.42	2.1
Price/Tangible Book Value Average	2.07	2.29	1.86	2.01	3.05	4.58	3.62	4.88	6.74	11.52	20.59	-10.5	-5.28	-10.14	1.32
Price/Tangible Book Value High	2.74	2.97	3.19	3.42	5.03	7.51	5.62	6.88	8.37	25.99	30.87	-21.22	-8.35	-22.01	2.56
Price/Tangible Book Value Low	1.72	1.39	0.97	1.07	1.95	3.23	2.43	2.86	4.85	6.1	12.91	-3.86	-2.91	-5.52	0.76
Price/Sales	105.19	216.57	34.79	24.12	9.27	11.02	109.31	8.3	6.04	5.44	3.03	2.15	2.16	1.65	2.62
Price/Sales Average	102.8	294.75	54.28	31.28	9.63	12.38	81.2	12.05	6.11	3.61	4.19	2.49	1.92	1.35	1.64
Price/Sales High	136.12	381.17	92.9	53.13	15.91	20.28	126.07	16.99	7.6	8.14	6.28	5.04	3.04	2.92	3.19
Price/Sales Low	85.59	178.92	28.2	16.58	6.18	8.71	54.65	7.07	4.4	1.91	2.63	0.92	1.06	0.73	0.95
Price/Cash Flow	-7.2	-5.72	-2.89	-2.85	-11.44	-2.96	-6.32	-6.28	-8.63	-11.32	76.86	-3.51	-43.93	9.4	10.18
Price/Cash Flow Average	-7.04	-7.78	-4.51	-3.7	-11.89	-3.32	-4.69	-9.12	-8.73	-7.51	106.4	-4.07	-39.09	7.67	6.39
Price/Cash Flow High	-9.32	-10.06	-7.72	-6.28	-19.64	-5.45	-7.29	-12.85	-10.85	-16.94	159.53	-8.22	-61.81	16.66	12.42
Price/Cash Flow Low	-5.86	-4.72	-2.34	-1.96	-7.63	-2.34	-3.16	-5.35	-6.29	-3.98	66.71	-1.5	-21.57	4.18	3.69
Price/Free Cash Flow Average	-7.04	-7.78	-4.51	-3.7	-11.89	-3.32	-4.69	-9.12	-8.73	-7.7	96.14	-4.09	24.25	7.63	6.69
Price/Free Cash Flow High	-9.32	-10.06	-7.72	-6.28	-19.64	-5.45	-7.29	-12.85	-10.85	-17.36	144.15	-8.27	38.35	16.57	13.01
Price/Free Cash Flow Low	-5.86	-4.72	-2.34	-1.96	-7.63	-2.34	-3.16	-5.35	-6.29	-4.08	60.28	-1.51	13.38	4.16	3.86
EV/Sales Average	98.88	279.87	51.36	29.44	8.13	11.51	72.66	10.34	6.35	3.69	4.27	2.64	2.16	1.36	1.69
EV/Sales High	132.2	366.28	89.99	51.29	14.41	19.42	117.53	15.27	7.83	8.22	6.36	5.18	3.27	2.94	3.24
EV/Sales Low	81.67	164.04	25.28	14.73	4.68	7.85	46.11	5.35	4.64	1.99	2.71	1.06	1.3	0.75	0.99
EV/EBITDA Average	-5.56	-6.5	-4.31	-2.73	-4.67	-3.72	-4.12	-6.38	-5.5	-14.18	-81.54	-5.96	-13.1	9.26	3.88
EV/EBITDA High	-7.44	-8.5	-7.55	-4.76	-8.28	-6.28	-6.66	-9.43	-6.78	-31.59	-121.51	-11.71	-19.88	19.96	7.45
EV/EBITDA Low	-4.6	-3.81	-2.12	-1.37	-2.69	-2.54	-2.61	-3.31	-4.02	-7.65	-51.68	-2.39	-7.88	5.1	2.28
EV/EBIT Average	-5.44	-6.34	-4.18	-2.66	-4.54	-3.67	-4.09	-6.33	-5.45	-13.83	-70.99	-5.85	-12.31	10.11	3.95
EV/EBIT High	-7.27	-8.29	-7.33	-4.64	-8.05	-6.19	-6.62	-9.35	-6.72	-30.82	-105.78	-11.49	-18.68	21.8	7.59
EV/EBIT Low	-4.49	-3.71	-2.06	-1.33	-2.61	-2.5	-2.6	-3.28	-3.98	-7.46	-44.99	-2.35	-7.4	5.57	2.32
Last Price	78.9	65	28.5	22.7	30.3	23.8	38.8	23	21.4	35	26.5	15	14.5	16.82	42.83
High Price	102.1	114.4	76.1	50	52	43.8	44.75	47.1	26.9	52.4	55	35.15	20.4	29.82	52.24
Enterprise Value Average	470	630	367	243	235	235	326	460	376	401	637	317	252	245	496
Enterprise Value High	628	824	643	423	416	396	527	680	464	893	949	623	383	527	952
Enterprise Value Low	388	369	181	122	135	160	207	238	275	216	404	127	152	135	292

Shares Outstanding	7	9	9	9	9	10	15	17	17	17	17	17	17	18	18
Diluted Weighted Avg Shares	6	7	9	9	9	9	13	16	17	17	17	17	17	18	19
Basic Weighted Avg Shares	6	7	9	9	9	9	13	16	17	17	17	17	17	18	18
Revenue per Share	0.75	0.3	0.82	0.94	3.27	2.16	0.35	2.77	3.54	6.44	8.75	6.97	6.72	10.2	16.36
EBITDA per Share	-13.33	-12.93	-9.76	-10.14	-5.69	-6.68	-6.27	-4.49	-4.09	-1.68	-0.46	-3.09	-1.11	1.5	7.11
Operating Income per Share	-13.64	-13.26	-10.06	-10.41	-5.85	-6.78	-6.3	-4.53	-4.13	-1.72	-0.53	-3.15	-1.18	1.38	6.98
Basic EPS, GAAP	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	20.4
Basic EPS from Cont Ops	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	20.4
Diluted EPS, GAAP	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	19.48
Diluted EPS from Cont Ops	-13.58	-13.18	-10.2	-10.37	-5.82	-7.33	-6.17	-4.39	-4	-1.76	-1.05	-3.4	-1.44	0.99	19.48
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-10.95	-11.37	-9.86	-7.96	-2.65	-8.04	-6.14	-3.66	-2.48	-3.09	0.34	-4.28	-0.33	1.79	4.21
Free Cash Flow per Basic Share	-10.95	-11.37	-9.86	-7.96	-2.65	-8.04	-6.14	-3.66	-2.48	-3.17	0.31	-4.3	-1.19	1.77	4.21
Cash & Equivalents per Share	39.1	39.78	24.28	16.33	14.28	7.92	9.16	8.01	5.86	3.4	7.33	3.38	3.27	4.4	8.61
Book Value per Share	-104.43	-101.4	-97.29	-107.24	-112.12	-112.38	-90.14	-75.32	-76.23	-77.38	-77.64	-80.18	-80.89	-79.07	-56.88
Tangible Book Value per Share	37.29	38.56	23.86	14.63	10.33	5.83	7.97	6.84	3.21	2.02	1.78	-1.66	-2.44	-1.35	20.39

Rigel Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)